Abstract:Abstract Background: Due to the rarity, the type 3 of maturity-onset diabetes of the young (MODY3) has not been explored comprehensively. The study aimed to describe and analyze the molecular and clinical characteristics of MODY3, which could help physicians understand the subtype of diabetes and increase the diagnosis rates in the future.Methods: Ten unrelated patients with suspected maturity-onset diabetes of the young (MODY) were included in the study based on information on family history and onset age. Sanger sequencing was used to identify cases with mutations in the hepatic nuclear factor 1A gene (HNF-1A). Results: Five patients were identified with MODY3, three cases (60%) with p.I27L mutation, one case (20%) with p.S487N mutation, and one case (20%) with p.G574S mutation. The average onset age was (23.00±3.00) years and the average age of diagnosis was (28.67±9.29) years. Most patients had typical clinical symptoms (polydipsia, polyuria, polyphagia, and weight loss). The main complications included diabetic ketoacidosis (DKA, 3/5,60%), diabetic macroangiopathy (2/5,40%), diabetic peripheral neuropathy (DPN,3/5,60%), diabetic nephropathy (DN,1/5,20%) and diabetic retinopathy (DR,1/5,20%). Four patients (80%) had fatty liver. The average body mass index (BMI) (26.39±4.67) kg/㎡, triglyceride (TG 2.95±1.43 mmol/L) and low-density lipoprotein (LDL-C 3.37±0.65 mmol/L) were beyond normal value. The glycosylated hemoglobin A1c (HbA1c 12.45±4.60 %), fasting plasma glucose (FPG 10.10±3.57 mmol/L) and postprandial plasma glucose (PPG 21.88±2.53 mmol/L) also increased dramatically. In addition, islet function examination revealed impaired secretion and slightly poor reserve function, which was similar to the changes inT2DM. All five patients used insulin, three (60%) also using antidiabetic drugs which did not include sulfonylureas.Conclusions: In brief, five patients were identified with MODY3. The mutation site could influence the onset age, the islet function and the incidence of complications. The age at diagnosis was 4.2 years later than the onset age. The control of diabetes was poor due to the inappropriate treatment. It is vital to make an early diagnosis and provide appropriate treatment for MODY3 patients.

Screening of Large Genomic Deletions and Duplications in the Hepatocyte Nuclear Factor 1β Gene in Patients Presented with a Clinical Phenotype Consistent with Maturity-Onset Diabetes of the Young Type 5

Progress of Diagnosis and Treatment for Maturity-Onset Diabetes of the Young

A Case of 17q12 Microdeletion Syndrome in a MODY5 Type Diabetes with HNF-1β Gene Mutation Accompanied

Identification of Four Novel Mutations in the Hnf-1a Gene in Chinese Early-Onset And/Or Multiplex Diabetes Pedigrees

Exon Sequencing of HNF1β in Chinese Patients with Early-Onset Diabetes

Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young

The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients

A Korean Family Presenting with Renal Cysts and Maturity-Onset Diabetes of the Young Caused by a Novel In-Frame Deletion of HNF1B

Scanning for MODY5 Gene Mutations in Chinese Early Onset or Multiple Affected Diabetes Pedigrees

Identification and Clinical Characteristics Analysis of HNF-1A Mutations p.I27L, p.S487N and p.G574S in Chinese Patients with MODY3

Recognition of Maturity‐onset Diabetes of the Young in China

A Novel Hepatocyte Nuclear Factor-1Α Genetic Mutation in a Chinese Pedigree with Maturity-Onset Diabetes of the Young Type 3

Studies of Genetic Variability of the Hepatocyte Nuclear Factor-1Α Gene in an Indian Maturity-Onset Diabetes of the Young Family.

Identification of HNF4A Mutation P.t130i and HNF1A Mutations P.i27l and P.s487n in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes

A New Clinical Screening Strategy to Distinguish HNF1A Variant-Induced Diabetes from Young Early-Onset Type 2 Diabetes in Chinese Population

Maturity Onset Diabetes of the Young (MODY) in Chinese Children: Genes and Clinical Phenotypes

Unusual manifestations of young woman with MODY5 based on 17q12 recurrent deletion syndrome

Prevalence of maturity-onset diabetes of the young in phenotypic type 2 diabetes in young adults: a nationwide, multi-center, cross-sectional survey in China

Detection of novel mutations related to maturity-onset diabetes of the young

Molecular Scanning for MODY5 Mutation in Beijing Population of Familial Early-Onset Type 2 Diabetes

A case of a novel mutation in HNF1β-related maturity-onset diabetes of the young type 5 with diabetic kidney disease complication in a Chinese family.